info@srobf.cz +420 495 832 176
CZ / EN
Pro odborníky

TOP TEN ASTRO 2015

1. Report of NRG Oncology/RTOG 9601, A Phase III Trial in Prostate Cancer: Anti-androgen Therapy (AAT) with Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) with pT2-3pN0 Disease and an Elevated PSA

2. Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer
in NRG Oncology_RTOG 0617.

3. Hypofractionated vs Conventionally Fractionated Radiotherapy for Prostate Cancer: 5-year Oncologic Outcomes of the Dutch Randomized Phase 3 HYPRO Trial.

4. Long-term Patient Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated IMRT Radiation Therapy for Localized Prostate Cancer.

5. Accelerated Partial Breast Irradiation Using Sole Interstitial Multicatheter Brachytherapy vs Whole Breast Irradiation for Early Breast Cancer: 5-year Results of a Randomized Phase III Trial – Part I: Local Control and Survival Results.

6. Involved-Field Irradiation vs Elective Nodal Irradiation for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Comparative Interim Analysis of Clinical Outcomes and Toxicities.

7. Noninvasive Evaluation of Metabolic Tumor Volume in LLC Tumor Bearing C57 Mice With PET and the Radiotracers 18F-Alfatide and 18F-FDG: A Comparative Analysis.

8. Contemporary Update of a Multi-institutional Predictive Nomogram for Salvage Radiation Therapy After Prostatectomy.

9. NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Low-Risk Prostate Cancer.

10. Quality of Life Outcomes: ASCENDE-RT a Multicenter Randomized Trial of Radiation Therapy for Prostate Cancer.

VÝZNAMNÉ RETROSPEKTIVNÍ STUDIE A METAANALÝZY

1. Survival Impact of Increasing Time to Treatment Initiation for Head and Neck Cancer in the United States

2. Survival Comparison of 3 Versus 4-5 Fractions for Stereotactic Body Radiation Therapy in Stage I Non-Small Cell Lung Cancer

3. Management and Outcomes of Clinical Stage II A/B Seminoma: Results From the National Cancer Data Base

4. Patterns of Care and Survival Outcomes Examining Radiation Therapy for Advanced Hodgkin Lymphoma.

5. Early-Stage, Low-Grade Follicular Lymphoma: How Much Evidence Do We Need to Adopt Radiation Therapy as the Primary Treatment?

6. Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer.

7. Comparative Effectiveness of Aggressive Locoregional Therapy in Metastatic Lung Cancer: Associations Between High-Dose Thoracic Radiation Therapy and/or Chemoradiation Therapy and Survival in a Large Population-Based Cohort

8. Risk of Secondary Malignancies after Radiation Therapy for Breast Cancer: Comprehensive Results

9. Radiation Therapy in Addition to Surgical Resection Improves Local Control for Retroperitoneal Sarcoma: A Systematic Review and Meta-Analysis.

10. The Impact of IMRT and Proton Beam Therapy on Overall Survival for Patients With Hodgkin Lymphoma.

6